Valuation Rigel Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-28 EDT			5-day change	1st Jan Change
50.74 ^USD	+0.38%		+3.81%	+18.47%

10-19	Rigel Pharmaceuticals, Inc. Highlights New GAVRETO® (Pralsetinib) Data Across RET Fusion-Positive Cancers At ESMO Congress 2026	CI
08-13	Rigel Pharmaceuticals Announces Availability Of VEPPANU (Vepdegestrant) For Patients With ER+/HER2-, ESR1-Mutated Advanced Or Metastatic Breast Cancer	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	453.2	259.3	252.8	296.3	777.4	947.8	-	-
Change	-	-42.79%	-2.48%	17.18%	162.39%	21.92%	-	-
Enterprise Value (EV)	453.2	259.3	252.8	296.3	777.4	947.8	947.8	947.8
Change	-	-42.79%	-2.48%	17.18%	162.39%	21.92%	0%	0%
P/E	-24.1x	-4.41x	-10.4x	17x	2.2x	16.2x	13x	11.9x
PBR	-	-	-	-	-	-	-	-
PEG	-	-0x	0.2x	-0x	0x	-0.2x	0.5x	1.22x
Capitalization / Revenue	3.04x	2.16x	2.16x	1.65x	2.64x	3.1x	2.54x	2.13x
EV / Revenue	0x	0x	0x	0x	0x	3.1x	2.54x	2.13x
EV / EBITDA	-0x	-0x	-0x	0x	0x	11x	6.97x	5.06x
EV / EBIT	-0x	-0x	-0x	0x	0x	11.5x	8.91x	6.99x
EV / FCF	-	-	-	-	-	-	12,151,491x	10,191,573x
FCF Yield	-	-	-	-	-	-	0%	0%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.1	-3.4	-1.4	0.99	19.48	3.135	3.898	4.278
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	149.2	120.2	116.9	179.3	294.3	305.7	372.8	444.8
EBITDA ¹	-7.813	-53.23	-19.25	26.42	127.9	85.86	136.1	187.2
EBIT ¹	-12.5	-55.55	-20.49	24.19	125.5	82.69	106.4	135.5
Net income ¹	-17.91	-58.57	-25.09	17.48	367	61.66	81.45	93.24
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	26.50	15.00	14.50	16.82	42.83	50.74	50.74	50.74
Nbr of stocks (in thousands)	17,101	17,284	17,437	17,615	18,151	18,680	-	-
Announcement Date	3/1/22	3/7/23	3/5/24	3/4/25	3/3/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
RIGEL PHARMACEUTICALS, INC.	16.19x	-	-	-.--%	948M
ELI LILLY AND COMPANY	37.84x	13.27x	28.43x	0.53%	1,148B
JOHNSON & JOHNSON	39.67x	6.67x	18.75x	1.97%	652B
ABBVIE INC.	37.4x	8.39x	17.35x	2.4%	505B
ROCHE HOLDING AG	21.45x	5.21x	12.93x	2.51%	384B
MERCK & CO., INC.	102.73x	5.76x	24.72x	2.42%	348B
NOVARTIS AG	21.89x	5.76x	13.88x	2.85%	294B
ASTRAZENECA PLC	22.21x	4.49x	12.82x	1.97%	264B
AMGEN INC.	28.66x	7.33x	13.12x	2.23%	244B
GILEAD SCIENCES, INC.	-45.79x	7.11x	27.55x	2.07%	197B
Average	28.23x	7.11x	18.84x	1.9%	403.81B
Weighted average by Cap.	35.28x	8.40x	20.64x	1.79%